title: Knowledge, attitudes, and behaviors regarding piperacillin-tazobactam prescribing practices: results from a multicenter study.
abstract: We investigated knowledge, attitudes, and behaviors of prescribers concerning piperacillin-tazobactam use at 4 Emory University-affiliated hospitals. Discussions during focus groups indicated that the participants' perceived knowledge of clinical criteria for appropriate piperacillin-tazobactam use was inadequate. Retrospective review of medical records identified inappropriate practices. These findings have influenced ongoing interventions aimed at optimizing piperacillin-tazobactam use.
authors.affiliation: Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. tantoine@cdc.gov
authors.forename: Theresa L
authors.initials: TL
authors.lastname: Antoine
authors.forename: Amy B
authors.initials: AB
authors.lastname: Curtis
authors.forename: Henry M
authors.initials: HM
authors.lastname: Blumberg
authors.forename: Kathryn
authors.initials: K
authors.lastname: Desilva
authors.forename: Mesfin
authors.initials: M
authors.lastname: Fransua
authors.forename: Carolyn V
authors.initials: CV
authors.lastname: Gould
authors.forename: Mark
authors.initials: M
authors.lastname: King
authors.forename: Alice A
authors.initials: AA
authors.lastname: Kraman
authors.forename: Jan
authors.initials: J
authors.lastname: Pack
authors.forename: Bruce
authors.initials: B
authors.lastname: Ribner
authors.forename: Ulrich
authors.initials: U
authors.lastname: Seybold
authors.forename: James P
authors.initials: JP
authors.lastname: Steinberg
authors.forename: Jane B
authors.initials: JB
authors.lastname: Wells
authors.forename: Ronda L
authors.initials: RL
authors.lastname: Sinkowitz-Cochran
authors.forename: Denise
authors.initials: D
authors.lastname: Cardo
authors.forename: John A
authors.initials: JA
authors.lastname: Jernigan
authors.forename: Robert P
authors.initials: RP
authors.lastname: Gaynes
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004363:Drug Utilization / Q000706:statistics & numerical data*; D017144:Focus Groups; D007722:Health Knowledge, Attitudes, Practice; D006785:Hospitals, University; D006801:Humans; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D018461:Soft Tissue Infections / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin